Table 3 Clinically relevant CNVs found in the patients with intellectual disability and developmental delay.

From: Chromosomal microarray analysis of 410 Han Chinese patients with autism spectrum disorder or unexplained intellectual disability and developmental delay

Region name

No. of subjects

Cytoband

CNV type

Size (kb)

Parent of origin

Pathogenicity

Genetic syndromes

1p36 deletion syndrome

2

1p36.33p36.23; 1p36.33p36.32

Deletion

4515–7908

De novo (2)

Pathogenic

1q21.1 microduplication syndrome

1

1q21.1q21.2

Duplication

1626

Maternal

Pathogenic

2q37 microdeletion syndrome

2

2q37.3

Deletion

3656–3973

De novo (2)

Pathogenic

Wolf-Hirschhorn syndrome

1

4p16.3p16.2

Deletion

5868

De novo

Pathogenic

Cri-du-chat syndrome

2

5p15.33p15.1; 5p15.31p15.1

Deletion

7595–16,576

De novo (2)

Pathogenic

5q trisomy syndrome

1

5q34q35.3

Duplication

15,248

De novo

Pathogenic

Sotos syndrome

1

5q35.2q35.3

Deletion

1911

De novo

Pathogenic

Silver–Russell syndrome

1

7p13q34

UPD

95,119

maternal

Pathogenic

Williams–Beuren syndrome

11

7q11.23

Deletion

1424–1570

De novo (11)

Pathogenic

Waardenburg syndrome

3

8p23.3p23.1

Deletion

6841–9905

De novo (1), unknown (2)

Pathogenic

Branchio–Otorenal syndrome

1

8q12.3q13.3

Deletion

10,009

De novo

Pathogenic

9 partial monosomy syndrome

1

9p24.3p23

Deletion

10,487

De novo

Pathogenic

9p partial trisomy

5

9p24.3p13.1; 9p24.3p21.1; 9p24.3q21.11; 9p24.3p21.13

Duplication (4), duplication x3 + duplication x4 (1)a

29,995–74,596

De novo (5)

Pathogenic

10p partial deletion

1

10p15.3p14

Deletion

11,049

De novo

Pathogenic

10p15.3 deletion syndrome

1

10p15.3p15.2

Deletion

3472

De novo

Pathogenic

Distal trisomy 10q syndrome

1

10q24.2q26.3

Duplication

35,938

De novo

Pathogenic

10qter deletion syndrome

1

10q26.2q26.3

Deletion

5640

De novo

Pathogenic

Prader–Willi syndrome (deletion)

2

15q11.2q13.1

Deletion

5259–6261

Paternal (2)

Pathogenic

Prader–Willi syndrome (UPD)

2

15q11.2q26.3

UPD (2)

79,659–79,677

Maternal

Pathogenic

Angelman syndrome (deletion)

1

15q11.2q13.1

Deletion

5239

Maternal

Pathogenic

Angelman syndrome (UPD)

1

15q11.2q21.1

UPD

25,942

Paternal

Pathogenic

15q11-q13 duplication syndrome

4

15q11.2q13.1; 15q11.2q13.2; 15q13.2q13.3

Duplication (1), duplication x3 (1), duplication x4 (1), duplication x3 + duplication x4 (1)b

4929–9674

De novo (3), unknown (1)

Pathogenic

15q26 deletion syndrome

1

15q26.3

Deletion

3134

Unknown

Pathogenic

16p13.11 microduplication syndrome

1

16p13.11

Duplication

1429

maternal

VUS

16p11.2 microduplication syndrome (BP4-BP5)

2

16p11.2

Duplication

586–826

De novo (1), unknown (1)

Pathogenic

16 partial trisomy syndrome

1

16q22.1q24.3

Duplication

19,668

De novo

Pathogenic

17 partial trisomy syndrome

1

17q25.3

Duplication

5701

De novo (1)

Pathogenic

18q deletion syndrome

4

18q21.2q21.31; 18q21.31q23; 18q21.33q23; 18q22.3q23

Deletion (3), deletion x1–2 (1)

3042–77,943

De novo (3), unknown (1)

Pathogenic

18q duplication syndrome

1

18q21.32q23

Duplication

77,943

De novo

Pathogenic

22q11.2 duplication syndrome

1

22q11.1q11.21; 22q11.21

Duplication x4 + duplication x3c

2893; 1682

De novo

Pathogenic

22q11.2 deletion syndrome

3

22q11.21

Deletion

2549–2884

De novo (3)

Pathogenic

MECP2 microduplication syndrome

2

Xq28

Duplication

377–424

Maternal (1), paternal (1)

Pathogenic

Other clinically relevant CNVs

1q25.1q31.1 deletion

1

1q25.1q31.1

Deletion

12,292

De novo

Pathogenic

2p16.1p12 deletion

1

2p16.1p12

Deletion

16,664

Unknown

Pathogenic

2p21p13.2 duplication

1

2p21p13.2

Duplication

28,560

De novo

Pathogenic

2p25.3p25.2 duplication

1

2p25.3p25.2

Duplication

6544

Unknown

Pathogenic

2q13 deletion

1

2q13

Deletion

1734

De novo

Likely pathogenic

3p14.1p11.1 duplication

1

3p14.1p11.1

Duplication

21,577

De novo

Pathogenic

4p16.3p16.1 duplication

1

4p16.3p16.1

Duplication

9452

Unknown

Pathogenic

4p16.3 deletion

1

4p16.3

Deletion

1195

Unknown

Pathogenic

4p16.2p16.1 duplication

1

4p16.2p16.1

Duplication

493

De novo

VUS

4q31.3q35.2 duplication

1

4q31.3q35.2

Duplication

38,587

Unknown

Pathogenic

4q34.14q35.2 duplication

1

4q34.14q35.2

Duplication

18,897

De novo

Pathogenic

6q23.3q24.2 deletion

1

6q23.3q24.2

Deletion

7405

Unknown

Pathogenic

7q11.22q21.11 deletion

1

7q11.22q21.11

Deletion

17,988

De novo

Likely pathogenic

8p23.3p22 deletion

1

8p23.3p22

Deletion

17,300

De novo

Pathogenic

13q21.1q32.2 deletion

1

13q21.1q32.2

Deletion

39,073

De novo

Pathogenic

14q11.2q21.2 duplication

1

14q11.2q21.2

Duplication

23,595

Unknown

Pathogenic

14q11.2q32.33 UPD

1

14q11.2q32.33

UPD

86,774

maternal

Pathogenic

14q32.12p32.33 duplication

1

14q32.12p32.33

Duplication

11,616

Unknown

Pathogenic

15q26.2q26.3 deletion

1

15q26.2q26.3

Deletion

3006

De novo

Pathogenic

16q24.2q24.3 duplication

1

16q24.2q24.3

Duplication

2671

Unknown

Pathogenic

18p11.32p11.31 deletion

1

18p11.32p11.31

Deletion

5987

De novo

Pathogenic

18p11.32p11.21 deletion

1

18p11.32p11.21

Deletion

13,649

De novo

Pathogenic

18q21.32q23 duplication

1

18q21.32q23

Duplication

19,416

De novo

Pathogenic

19p13.2 deletion

1

19p13.2

Deletion

2260

De novo

Likely pathogenic

19p13.3p13.2 duplication

1

19p13.3p13.2

Duplication

7327

De novo

Pathogenic

20p13 deletion

1

20p13

Deletion

978

De novo

Pathogenic

20p13p12.3 deletion

1

20p13p12.3

Deletion

9844

Unknown

Pathogenic

21q22.11q22.3 deletion

1

21q22.11q22.3

Deletion

13,055

De novo

Pathogenic

21q22.3 duplication

1

21q22.3

Duplication

2858

De novo

VUS

22q13.31q13.33 duplication

2

22q13.31q13.33

Duplication

5648

Unknown (2)

Pathogenic

Xq22.3q27.1 duplication

1

Xq22.3q27.1

Duplication

32,324

Unknown

Pathogenic

  1. UPD uniparental disomy, VUS variant of uncertain significance.
  2. aThis subject has a de novo duplication (x4) of chr9:203,861–4,199,819, immediately adjacent to a de novo duplication (x3) of chr9:4,199,820–38,787,479.
  3. bThis subject has a duplication (x4) of chr15:22,770,421–31,073,668, immediately adjacent to a duplication (x3) of chr15:31,073,668–32,011,459.
  4. cThis subject has a de novo duplication (x4) of chr22:16,888,899–19,781,868, immediately adjacent to a de novo duplication (x3) of chr22:19,783,504–21,465,659.